✦ LIBER ✦

Esophagomyotomy and esophagopexy to create a diverticulum for treatment of chronic esophageal stricture in 2 horses

✍ Scribed by James D. Lillich; Karl E. Frees; Kathrine Warrington; Philip D. Van Harreveld; Earl M. Gaughan; Warren L. Beard

Book ID: 111723658
Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 782 KB
Volume: 30
Category: Article
ISSN: 0161-3499
DOI: 10.1053/jvet.2001.25870

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An educational programme for peer review

An educational programme for peer review groups to improve treatment of chronic heart failure and diabetes mellitus type 2 in general practice

✍ Willeke N. Kasje; Petra Denig; Roy E. Stewart; Pieter A. De Graeff; Flora M. Haa 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

2-Chlorodeoxyadenosine treatment in non-

2-Chlorodeoxyadenosine treatment in non-Hodgkin's Lymphoma and B-cell chronic lymphocytic leukemia resistant to conventional chemotherapy: results of a multicentric experience

✍ M. Brugiatelli; B. Holowiecka; A. Dmoszynska; O. Krieger; A. Planinc-Peraica; B. 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 165 KB

Induction doses of interferon-α-2a in co

Induction doses of interferon-α-2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non-responders to interferon monotherapy: a randomized trial

✍ J. Salmerón; M. Diago; R. Andrade; R. Pérez; R. Solá; M. Romero; M. De La Mata; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

The in-vivo effect of bakumondo-to (TJ-2

The in-vivo effect of bakumondo-to (TJ-29), a traditional Japanese medicine used for treatment of chronic airway disease, on cytochrome P450 1A2, xanthine oxidase and N-acetyltransferase 2 activity in man

✍ Junji Saruwatari; Shinichirou Hisaeda; Yoko Higa; Yuko Tomiyasu; Kazuko Nakagawa 📂 Article 📅 2004 🏛 Pharmaceutical Press 🌐 English ⚖ 163 KB

Variants in interferon-alpha pathway gen

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial

✍ Tania Mara Welzel; Timothy R. Morgan; Herbert L. Bonkovsky; Deepa Naishadham; Ru 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

Combination treatment with pegylated-interferon-alpha (PEG IFN-␣) and ribavirin, the current recommended therapy for chronic hepatitis C virus (HCV) infection, results in a sustained virological response (SVR) in only about half of patients. Because genes involved in the interferon-alpha pathway may

Rapid clearance of hepatitis C virus RNA

Rapid clearance of hepatitis C virus RNA in peripheral blood mononuclear cells of patients with clotting disorders and chronic hepatitis C treated with alpha-2b interferon is not a predictor for sustained response to treatment

✍ K. Peerlinck; M. Willems; L. Sheng; F. Nevens; J. Fevery; S. H. Yap; J. Vermylen 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 387 KB